Eli Lilly, Takeda Plan Appeal Of $37M Actos Ruling
Takeda Pharmaceuticals International Inc. and Eli Lilly & Co. said Thursday they will appeal a $37 million punitive damages ruling against them in a suit that alleged the company hid the...To view the full article, register now.
Already a subscriber? Click here to view full article